Clave Mayor

Clave Mayor SGEIC, S.A., formerly known as Clave Mayor, S.A., S.G.E.C.R. is a private equity and venture capital firm specializing in incubation stage, seed, start-up, early stage, mature, buyouts, growth capital, and emerging growth investments. It prefers to invest in tech transfer, spin-off from Universidad Politècnica de València. It typically invests betweeen €0.5 million and €5 million in companies located in Spain and also considers investing in companies located in the European Union. Clave Mayor, S.A., SGEIC was founded in June 2002 and is based in Pamplona, Spain with additional offices in Valladolid, Spain and Valencia, Spain.
JA

Jose Armendariz

Presidente / Ceo

Francisco Armero

Director de Fondos Director Castilla Y Leon

JC

Juan Carlos Franquet

Socio

Santiago Lozano

Director de Fondos

CM

César Mendoza

Director de Fondos

Isidoro Parra

President

JL

José León Taberna

Socio

Pedro de Álava

Asociado / Director Valencia

28 past transactions

DCWafers

Series A in 2008
DCWafers is the first ever Spanish company dedicated to the production of polycristaline silicon wafers for the photovoltaic industry. DCWafers will gradually begin production half way into 2008, gaining complete production capacities at the end of 2008. DC Wafers’ Initial production capacity is 13 million wafers per year for which DCWafers have secured the supply of raw materials and ordered the best equipment available on the market. The managing team in DCWafers is made up of business people with extensive experience and technical expertise in the industry, also having an advisory board made up of industry leaders both in management and research.

Aspil

Venture Round in 2015
Aspil manufacturer snacks foods.

Kronomav Sistemas

Convertible Note in 2013
Kronomav is an audiovisual engineering firm manufacturing and rental robotized machinery for TV and Film camera movement, besides Kronomav have developed a stereoscopic 3D system. The company specializes in offering its clients customized solutions made all the more easy to implement owing to the versatility inherent to a manufacturer as well as its strong commitment to research and development.

Ojer Pharma

Private Equity Round in 2023
Laboratorios Ojer Pharma S.L. produces and markets dermo-pharmaceutical products. It offers prescription medicines, cosmetics, and medical devices. The company also provides research and development services for pharmaceutical and dermo-pharmaceutical products. Additionally, it develops a vehiculization technology in the form of bioadhesive transparent gel, which acts as a sustained-release matrix of dermatological actives, such as lipophilics and hydrophilics. The company was founded in 2005 and is based in Pamplona, Spain.

Bionostra

Series B in 2005
It is one of the largest companies in the Spanish biotechnology sector. Its activity focuses on research, development and commercialization of biotechnology services. Born in 2000 under the initiative of a group of researchers of the Higher Council for Scientific Research (CSIC) and business professionals and is one of four companies in the business group Bionostra.

Predictheon

Seed Round in 2021
Predictheon develops software for healthcare professionals. Predictheon develops software-based monitoring solutions for the prediction of clinically relevant real-time patient metrics and outcomes in different areas of anesthesia and perioperative care.

Ibetor

Series A in 2010
Ibetor S.L. engages in design and development of flat antenna for satellite telecommunications. The company was founded in 2009 and is based in Las Rozas, Spain.

WiTraC

Seed Round in 2019
WiTraC Comunicaciones Inteligentes, S.L. provides wireless location, control, and tracking of elements (people, animals or assets) for automotive, logistics, rail, and aeronautical industries. Its offers RTLS systems, Industry 4.0, that improves industrial and logistics operations. It enables to know the positioning of the assets, tracking them with the help of their web management platform, and communicate in real time through the web platform. The company was incorporated in 2012 and is based in Valencia, Spain.

Red Karaoke

Series A in 2008
Red Karaoke is an online platform that enables users to sing and record their karaoke sessions via the web or smartphones in English, Spanish, and Japanese. The company’s business model is based on a free basic service, subscription driven premium service tiers, and also a pay-per-use model for some additional contents or services. Red Karaoke was founded by Miguel Angel Diez Ferreira and Richard Diez Ferreira in April 2007 and is based in San Francisco, California.

Tweet Binder

Seed Round in 2017
Social Media solutions for: - Analytics - Events - Digital Marketing - Festivals. - Hashtags campaigns If you want to get real time and great analytics on Twitter, make sure you use our suite. The Team will be happy to help you at anytime.

Mr Jeff

Series B in 2020
Jeff is a company created in 2015 by Eloi Gómez, Adrián Lorenzo and Rubén Muñoz, three Spanish entrepreneurs. It started as a home laundry and dry-cleaning app, but is currently in an expansion process in which, in addition to laundry service, different day-to-day services are added such as hairdressing and beauty, fitness and massages, becoming the first international omnichannel ecosystem of day-to-day services. It is available to anyone who wants to invest or undertake the necessary solutions to launch their own business under the business lines of the Jeff brand.

INCOM Storage

Venture Round in 2010
Incom Storage is a company specializing in the sale of optical storage systems, Blu-Ray, CD and DVD as well as devices for publishing and distributing information on CD / DVD, not to mention the procedures copy DVDs. The solution currently provides primary and secondary file with innovative products in information storage.

Vivia Biotech

Series B in 2012
Launched in September 2007, Vivia Biotech is a world pioneer of individualized medicine, profiling thousands of drugs and combinations in a single patient sample, by means of its proprietary PharmaFlow Technology Platform. The PharmaFlow technology was originally developed in the USA by an American team who moved to Spain and launched Vivia Biotech, where they could efficiently leverage Spain’s world-leading position in altruistically donation of tissue and organ samples for research, with the first technology worldwide enabling scale research in patient samples. Vivia has developed PharmaFlow PM, a precision medicine test for the treatment of Hematological Malignances like Leukemia and Multiple Myeloma, that seeks to identify the best treatment option for each individual patient. Vivia has also pioneered worldwide the development of “native environment” assays in whole patient samples across several indications and multiple mechanisms of action, capable of delivering truly translational pharmacological data that correlates with patient treatment outcome. With these assets, Vivia has successfully engaged in partnering with pharmaceutical and biotechnology companies worldwide to provide unique precision medicine capabilities for patient-centric drug development and biomarker discovery. Vivia’s team is made of highly qualified professionals, dedicated to improve the life expectancy and quality of life of cancer patients.

Vivotecnia Research S.L

Venture Round in 2007
Vivotecnia offer services to support the preclinical development of biotechnology and pharmaceutical products as well as safety studies for cosmetic, chemical and agro-chemical companies.

Mevion Technology

Seed Round in 2012
Mevion Technology offers industrial ionization services for the sterilization of different products. It uses a modern electron beam accelerator which is able to sterilize products, sanitize food, and improve the properties of different materials. The company is based in Olvega, Spain.

Venter Pharma SL

Venture Round in 2014
Venter Pharma SL, a biotech company, develops diagnostic drugs for the diagnosis of lactose intolerance. It develops LacTEST, a diagnostic drug that helps professionals to manage the lactose intolerance disease. Venter Pharma SL was formerly known as Lactest SL. The company was founded in 2003 and is based in Alcobendas, Spain.

Futura Acorp

Venture Round in 2007
Futura Acorp S.L. develops and markets technological solutions for hotel sector in Spain. Its technological systems allow the clients of hotels to deliver the orders and carry out the payment of such, without the intervention of a waiter. The company also develops tracking system based on radio frequency identification technology for the process of beverages production and management of warehouse. The company was founded in 2005 and is based in Navarra, Spain.

Fast Drinks

Seed Round in 2013
Fast Drinks was launched in April 2005 for the development of the concept 2GO SHC (Self-Heating Can). Starting with the initial idea of producing a coffee beverage we went further to develop this idea creating a new solution with self-heating containers. To develop this concept, we have invested 3 years in R & D and are now currently selling these self-heating beverages in Spain, France, Great Britain, Scandinavia, USA and Japan.

Telum Therapeutics

Seed Round in 2020
Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.

Angelpc Global Support

Venture Round in 2007
Angelpc Global Support, S.L. provides permanent online personal computer support services. It offers personal computer helpdesk services, and software support and technical incident solutions by remote control. The company's service coverage includes local free telephone contact and support in the use of Microsoft Office, as well as support for local printers management and use, virus clean-up, information backup, network printers management and use, network servers units, users maintenance, servers updates, and general user's incidents. Angelpc Global Support is based in Navarra, Spain.

Digna Biotech

Venture Round in 2007
Digna Biotech is a spin-off of the Centre for Applied Medical Research (CIMA) of the University of Navarra in Pamplona, jointly owned by the Foundation for Applied Medical Research (Fundacian para la Investigacian Macdica Aplicada, FIMA), and a consortium of private investors. Among the latter are some of the mayor corporations of Spain, incluiding major institutions of Navarra such as University of Navarra, Caja Navarra, Caja Rural de Navarra, and the Government of Navarra through its investment arm SODENA.

Idifarma Desarrollo Farmacéutico

Venture Round in 2016
Idifarma is a leading Spanish CDMO since 2001 that provides services to over 100 international pharmaceutical companies Our main objective is to provide pharmaceutical development and manufacturing services tailored to our clients’ needs. Thanks to our wide range of services, our high-performance equipment and a strict quality control system, we can offer efficient solutions within set deadlines.

Comercial TV

Venture Round in 2009
Commercial TV is a distributor of audiovisual content that was created to serve the Local TV with the aim of becoming the leading travel industry. Commercial TV offers a wide national and international titles catalog and care of all genres of the most prominent and recognized the audiovisual landscape suppliers, and makes on-line available to local television.

Casa Eceiza

Venture Round in 2007
Casa Eceiza focusses on manufacturing biscuits and confectionery products that keep for long periods of time, following classic bakery systems. Case Eceiza is fully committed to making products that achieve complete customer satisfaction when consumed; products with personality, organoleptically superior, based on noble ingredients, free from hydrogenated vegetable oils, dyes, or artificial flavouring, manufactured in a way that preserves the quality of the ingredients, using traditional recipes, and taking great care in the presentation of the end products.

Kronomav Sistemas

Venture Round in 2008
Kronomav is an audiovisual engineering firm manufacturing and rental robotized machinery for TV and Film camera movement, besides Kronomav have developed a stereoscopic 3D system. The company specializes in offering its clients customized solutions made all the more easy to implement owing to the versatility inherent to a manufacturer as well as its strong commitment to research and development.

DomoBlue S.L.

Venture Round in 2007
Domoblue specialized in home automation services and in the development of vehicle or people tracking systems.

Amadix

Venture Round in 2013
Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide. The most advanced product developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients). Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.

TCD Pharma

Series A in 2010
Chosen as one of Spain’s top 5 biotech investment opportunities, TCD is focused on creating the future of Oncology by developing innovative therapies that address unmet medical needs. Established in 2005 and with one product, TCD-717, already in clinical trials the Company is positioning itself as Spain’s Partner of Choice for Oncology drug discovery and development opportunities. TCD’s strong management team, its strategy of building its pipeline through in-licensing and partnerships and by leveraging resources through collaborations and outsourcing via premier Contract Research Organizations, allows TCD to be in the forefront of Oncology drug development while significantly lowering risks and costs.